Prospect News: News for US Oncology, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with U > Issuers starting with U, HY only > All stories on US Oncology, Inc. > Stories on US Oncology, Inc., HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

US Oncology, Inc.

2/17/2011	HYLM	US Oncology redeems 9 1/8% notes, 103/4% notes for $1.2 billion
2/14/2011	HY	Market Commentary: Cambium prices, firms; market awaits Clear Channel; Hughes Network up on EchoStar buyout deal
2/8/2011	HY	Market Commentary: Chesapeake Energy, Avaya, Ally price in $4 billion day; existing Chesapeake bonds keep firming
2/8/2011	HYLM	Indenture imbroglio seen holding key to U.S. Oncology issue's slide
2/4/2011	HY	Market Commentary: Aleris, Yankee Candle lead late deal surge; OPTI, Kodak extend comebacks; US Oncology a puzzle
12/31/2010	HYLM	US Oncology issues call for notes prior to acquisition by McKesson
11/30/2010	HY	Market Commentary: Murray, Vector price add-ons; Paramount upsizes; TransDigm ahead; Baldor up on buyout news
11/29/2010	HY	Market Commentary: Post-holiday session quiet, though primary calendar builds with TransDigm, Citadel, CDW deals
11/1/2010	HYLM	US Oncology notes to be repaid or refinanced in buyout by McKesson
8/26/2010	HY	Market Commentary: Interoil deal prices; Blockbuster rises; GM, Motorola busy; funds gain $315.49 million on week
8/5/2010	BKBWHY	U.S. Oncology says second-quarter results impacted by weak patient volumes, strategic investments
9/11/2009	BKHY	S&P gives U.S. Oncology loan BB- rating
6/29/2009	HY	Market Commentary: UAL prices deal; Targa, Royal Caribbean slate deals, busy Tuesday expected; new paper holds
6/8/2009	BKHY	Moody's: US Oncology unchanged
6/5/2009	HY	Market Commentary: Re-tooled Western prices, Holly too; Thursday deals trade up; Michaels rises again, Cott adds
6/4/2009	HY	New Issue: US Oncology sells upsized $775 million 9 1/8% eight-year notes at 97.926 to yield 91/2%
6/4/2009	HY	Market Commentary: Upsized Mariner, U.S. Oncology price; junk tone softer; Michaels up on results; funds jump $918 million
6/4/2009	BKHY	S&P rates US Oncology notes B
6/4/2009	BKHY	Moody's rates US Oncology notes Ba3
12/17/2008	HY	Market Commentary: Better junk tone despite stock slump; Opti Canada, Charter, lead gainers; GMAC gains on exchange progress
11/6/2008	HY	US Oncology chooses PIK option for senior subordinated notes' March payment
10/23/2008	HY	Market Commentary: WaMu whacked on CDS auction; Level 3 outlook hurts; Q4 hope aids Smurfit Stone; funds up $72 million
11/9/2007	HY	US Oncology to pay PIK interest on notes for period ending March 15
9/12/2007	BKHY	Moody's cuts US Oncology
9/10/2007	BKHY	S&P lowers US Oncology
8/14/2007	BKHY	S&P: US Oncology on watch
3/2/2007	HY	Market Commentary: Alliance One deal prices; Dean Foods drops; airlines keep falling amid market woes
3/1/2007	HY	New Issue: US Oncology prices $425 million Libor plus 450 bps floating-rate toggle notes at 98.00
2/27/2007	BKHY	S&P rates US Oncology notes B-
2/27/2007	BKHY	Moody's upgrades US Oncology, rates note B3
2/20/2007	HY	US Oncology to sell $400 million PIK toggle floaters via Citigroup
2/20/2007	HY	Market Commentary: XM, Sirius bonds in orbit on merger news; Movie Gallery up; Rexnord sells toggle loan
9/29/2006	BKHY	Moody's introduces new ratings
6/12/2006	BKHY	Moody's rates US Oncology loan Ba3, ups some ratings
6/12/2006	BKHY	S&P rates US Oncology loan B+
3/15/2005	BKHY	Moody's cuts US Oncology loans to B1, rates notes Caa1
3/15/2005	BKHY	S&P: US Oncology cut to negative, notes rated B-
3/15/2005	HY	Market Commentary: DaVita brings giant two-part deal, US Oncology, Exide also price; Triton falls on earnings warning
3/15/2005	HY	New Issue: US Oncology $250 million 10-year notes yield 6-month Libor plus 525 bps
3/14/2005	HY	Market Commentary: Swift sells five-year notes; Dobson bonds firmer on asset sale plan
3/14/2005	HY	US Oncology to price $250 million 10-year floaters Tuesday or Wednesday
8/20/2004	HY	US Oncology buys $172 million 9 5/8% notes in tender
8/16/2004	HY	US Oncology again extends tender, consent deadlines for 9 5/8% notes
8/5/2004	HY	Market Commentary: $980 million of new deals; Levi better on Dockers sale hopes; $29 million funds outflow
8/4/2004	HY	Market Commentary: Blount, U.S. Oncology, Borden deals price; Charter gyrates on equity infusion buzz, CFO exit
8/4/2004	HY	New Issue: US Oncology prices restructured $575 million two-part note offering
8/2/2004	HY	Market Commentary: Stanadyne 10-year deal prices; Primus rebounds, J.C. Penney firms on asset sale news
8/2/2004	HY	US Oncology talks $200 million senior notes at 9% area, $375 million subs at 101/4% area
7/22/2004	HY	Market Commentary: Refco, Loews, Fisher price deals, EchoStar scrubbed; Goodyear easier; funds see $196 million inflow
7/22/2004	HY	US Oncology to start roadshow Monday for $575 million two-part deal
7/19/2004	HY	US Oncology again extends tender for 9 5/8% notes
6/7/2004	HY	US Oncology extends tender for 9 5/8% notes
5/28/2004	HY	Market Commentary: Trump jumps on coupon payment; Curative lower on California setback
5/28/2004	HY	U.S. Oncology coming in June with two-part, $675 million offering
5/27/2004	HY	U.S. Oncology to bring $675 million, two-part notes offering via Citigroup
5/27/2004	BKHY	Moody's rates U.S. Oncology
5/26/2004	BKHY	S&P cuts U.S. Oncology
5/21/2004	HY	US Oncology tenders for 9 5/8% notes
4/5/2004	BKHY	Moody's may cut U.S. Oncology
3/22/2004	BKHY	US Oncology plans $550 million credit facility, $625 million bonds to help fund LBO
3/22/2004	BKHY	S&P puts U.S. Oncology on watch
3/22/2004	HY	Market Commentary: Interactive Health Finance, MTU Aero price deals; secondary quiet
2/9/2004	HY	S&P: U.S. Oncology ratings unaffected
2/5/2004	BKHY	S&P affirms US Oncology ratings
10/7/2003	BKHY	S&P cuts Land O'Lakes
7/11/2003	BKHY	S&P puts JLG on watch
1/28/2002	HY	Market Commentary: Global Crossing crosses over into bankruptcy, bonds trade in single digits
1/25/2002	HY	Market Commentary: Kmart easier on accounting concerns; Moody's upgrade lifts Amazon; PanAmSat upsizes
1/25/2002	HY	New Issue: U.S. Oncology $175 million 10-year notes yield 9 5/8%
1/24/2002	HY	Kmart active but little changed; Haliburton, Georgia Pacific bounce after sharp declines
1/24/2002	HY	U.S. Oncology benefits from demography; $175 million notes talked at 91/2%-93/4%
1/18/2002	HY	S&P cuts Goodyear to junk
1/15/2002	HY	S&P downgrades Williams Communications, on negative watch
1/10/2002	HY	Market Commentary: Kmart bonds retreat as retailer warns of softer earnings, notes talks with lenders
1/10/2002	HY	US Oncology starts roadshow for $175 million 10-year notes Jan. 15
1/10/2002	HY	Tenders

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.